Similar Articles
Posterior Reversible Encephalopathy Syndrome in the Late Postpartum Period: A Case Report
Merve Melodi Çakar, Sezgin Kehaya, Hülya Özkan, Babürhan Feyzullah Güldiken
DOI: 10.4274/tnd.65481
Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years
Nefati Kıylıoğlu
DOI: 10.4274/tnd.79836
Posterior Auricular Muscle Response: Observations in Brainstem Lesions
Yeşim Gülen Abanoz, Yasin Abanoz, Yasemin Akıncı, Ayşegül Gündüz, Eser Buluş, Melih Tütüncü, Sabahattin Saip, Meral Erdemir Kızıltan
DOI: 10.4274/tnd.57255
Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.86977
Cerebral Palsy and Genetics
Nihan Hande Akçakaya, Zuhal Yapıcı, Uğur Özbek
DOI: 10.4274/tnd.67864
Mortality in Patients with Multiple Sclerosis
Sümeyra Şamlı, Murat Kürtüncü
DOI: 10.4274/tnd.15921
Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!
Mohamed S A Mohamed
DOI: 10.4274/tnd.65882
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir
DOI: 10.4274/tnd.62144
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya
Mustafa Çetiner, Sibel Canbaz Kabay, Hasan Emre Aydın
DOI: 10.4274/tnd.35651
Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study
Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ
DOI: 10.4274/tnd.37074
Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis
Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu
DOI: 10.4274/tnd.87523
Acute Spinal Pseudoathetosis
Mehmet Fevzi Öztekin, Dilara Mermi Dibek
DOI: 10.4274/tnd.27167
Weight Loss and Fingolimod
Nefati Kıylıoğlu
DOI: 10.4274/tnd.87528
One-year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
Mustafa Karaoğlan
DOI: 10.4274/tnd.37097
The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis
Şenay Yıldız Çelik
DOI: 10.4274/tnd.71354
Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis
Ahmed Serkan Emekli
DOI: 10.4274/tnd.90018
Late-onset Tremor and Ataxia Syndrome: Fragile X-Associated Tremor/Ataxia Syndrome and Neuroimaging Findings
Levent Öcek, Onural Tümer, Figen Tokuçoğlu, Özgür Öztekin, Yaşar Zorlu
DOI: 10.4274/tnd.68878
The Predictive Role of NEDA in the Long-Term Course of Multiple Sclerosis
Özgü Kizek
DOI: 10.4274/tnd.65391
Steroid Withdrawal related Relapse in a Patient with Neuro-Behçet’s Disease
Bekir Enes Demiryurek
DOI: 10.4274/tnd.80008
Does Serum Vitamin D Level During Pregnancy Influence the Risk of Multiple Sclerosis?
Tuncay Gündüz
DOI: 10.4274/tnd.28566